Skip to Content
Merck
CN

Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis.

PloS one (2019-12-07)
Felix Sellberg, Fanny Fredriksson, Thomas Engstrand, Tim Melander Bowden, Bo Nilsson, Jaan Hong, Folke Knutson, David Berglund
ABSTRACT

The objective of this study was to investigate whether a soluble polymer and aldehyde-scavenger, polyvinylalcohol-carbazate (PVAC), can inhibit hemolysis in the storage of red blood cells (RBC). The effect of PVAC was assessed over a wide range of concentrations, using absorption spectroscopy to evaluate the level of hemolysis. Moreover, osmotic stability and aldehyde-scavenging potential of RBC were assessed after storage in PVAC. After test tube storage for two weeks, red blood cell hemolysis was lower with PVAC compared to controls (mean difference 23%, 95% CI 16-29%, p < 0.001). A higher level of hemolysis led to a pronounced effect with PVAC. RBC stored in PVAC improved both the binding of free aldehydes (p <0.001) and the osmotic stability (p = 0.0036). Erythrocytes stored with PVAC showed less hemolysis, which might be explained by the ability of PVACs to stabilize the cell membrane and decrease oxidative injury.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethyl carbazate, 97%